Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

ADMA Adma Biologics Inc

17,40

-0,50 (-2,79%)

21 Dic 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/09/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Lawrence P. Guiheen

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Adma Biologics (NASDAQ:ADMA)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Adma Biologics

Grafico Azioni Adma Biologics (NASDAQ:ADMA)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Adma Biologics

Notizie Adma Biologics Inc - ADMA

Form 8-K - Current report
Venerdì 20 Dicembre 2024 (15 ore fa) • Edgar (US Regulatory)

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
Venerdì 20 Dicembre 2024 (15 ore fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Sabatp 23 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Sabatp 23 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sabatp 23 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sabatp 23 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 21 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Giovedì 7 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 7 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
Giovedì 7 Novembre 2024 (1 mese fa) • GlobeNewswire Inc.

Form 8-K - Current report
Giovedì 31 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
Martedì 29 Ottobre 2024 (2 mesi fa) • GlobeNewswire Inc.

Più Adma Biologics Inc Articoli Notizie

Arcadium Lithium

Ifc Zc Ge37 Mxn

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea